New future for Italian oncology and neurology centres:
This article was originally published in Clinica
Italy's flagship oncology centre, the National Tumour Institute (INT), may be sold to the state insurance group Inail, in a transaction that promises renewed investment in its facilities. Talks are underway for Inail to buy and lease the Milan-based buildings at a favourable rate that would enable the INT to settle debts that "threaten its very survival and hinder its relaunch and development", said the health ministry. Similar negotiations are underway with Inail, the body responsible for Italy's obligatory work-related health and safety insurance, regarding the forthcoming development of the new Carlo Besta Neurology Institute, relocated within Milan.